James Vaughn
2016
In 2016, James Vaughn earned a total compensation of $1.6M as Chief Commercial Officer at Genomic Health, a 22% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $228,800 |
|---|---|
| Option Awards | $726,905 |
| Salary | $400,000 |
| Stock Awards | $284,850 |
| Total | $1,640,555 |
Vaughn received $726.9K in option awards, accounting for 44% of the total pay in 2016.
Vaughn also received $228.8K in non-equity incentive plan, $400K in salary and $284.9K in stock awards.
Rankings
In 2016, James Vaughn's compensation ranked 5,826th out of 14,075 executives tracked by ExecPay. In other words, Vaughn earned more than 58.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,826 out of 14,075 | 59th |
Division Services | 1,015 out of 2,282 | 56th |
Major group Health Services | 90 out of 209 | 57th |
Industry group Medical And Dental Laboratories | 19 out of 61 | 69th |
Industry Medical Laboratories | 19 out of 61 | 69th |
Source: SEC filing on April 28, 2017.
Vaughn's colleagues
We found four more compensation records of executives who worked with James Vaughn at Genomic Health in 2016.